MSF Foundation Supports Epicentre in New Yellow Fever Study
Share
Share on Facebook
Share on Telegram
Share on LinkedIn
Share on Twitter
Copy link
Page url is copied
The study began in July 2017. It will enroll 960 participants supported at Epicentre's research center in Mbarara, Uganda, and the Kilifi Medical Research Institute in Kenya.
Cervical cancer is the second deadliest cancer in low- and middle-income countries (1). In Malawi in East Africa, where MSF operates, over 4,000 Malawian women fall sick with cervical can...
